Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569435 · ClinicalTrials.gov registry record · Phase 2
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 study, sponsored by Annexon.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT04569435 is a Phase 2 study that has completed, run by Annexon. The registered enrollment target is 17 participants.
The verdict
NCT04569435, a Phase 2 study, has completed, sponsored by Annexon.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.
Interventions
- DRUG ANX005
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2024-04-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04569435
The ClinicalTrials.gov registry entry for NCT04569435 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Annexon, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ANX005 is the first listed.
NCT04569435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04569435 about?
NCT04569435 is a clinical study titled "Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)". This study is a multi-center, open-label study of intravenous (IV) ANX005 in participants with ALS.
What is the current status of trial NCT04569435?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2021-01-15. Estimated completion is 2024-04-23.
What interventions are being tested in trial NCT04569435?
The interventions under investigation include: ANX005 (DRUG).
Who is sponsoring clinical trial NCT04569435?
This trial is sponsored by Annexon, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.